The Clinical Sciences and Innovation (CS&I) department in NIBR Translational Medicine is a dynamic group of clinical scientists responsible for the conduct and evaluation of Phase I and Phase IIa clinical studies. These studies are designed to profile safety, tolerability, pharmacokinetics, and pharmacodynamics and to provide early proof of efficacy of novel compounds in humans. CS&I in Cambridge, MA, specializes in early clinical research in diabetes, cardiovascular and metabolic conditions, ophthalmology, neuroscience, respiratory, and infectious diseases. Globally, CS&I also performs clinical research in autoimmunity, musculoskeletal disorders, dermatology and transplantation. Over 100 clinical sciences experts in multiple CS&I locations worldwide strive to provide a smooth transition from discovery research to clinical practice and enable potential medicines to be tested more effectively in humans.
Over the course of the Fellowship, the Fellows will:
Lead and participate in the clinical trial team to impact study design, conduct and analysis
Develop clinical trial protocols
Contribute to the design of data capture tools and statistical analysis plans
Create and obtain essential regulatory trial documents
Orchestrate operational aspects of clinical trials including selection and oversight of clinical trial centers and external vendors
Participate in the analysis of study data and the preparation of final study reports
Contribute to writing of Investigator’s Brochure, briefing books and safety updates
Understand and comply with Good Clinical Practice (GCP) and regulatory requirements
Learn to work cross-culturally with colleagues and study sites around the world
Applicants must upload the following application materials to the online portalby December 2nd,2019:
Letter of intent
Unofficial college transcript
Contact information of three references for recommendations
Incomplete applications WILL NOT be reviewed. ASHP Clinical Midyear Meeting interviews CANNOT be scheduled until these materials have been submitted. Please keep in mind that this is a competitive process and applicants are encouraged to complete their applications as soon as possible.
*Early submission is recommended due to limited interview slots. Interviews will be scheduled on a first-come, first-serve basis.
After ASHP Midyear Clinical Meeting
The three recommendation must be submitted by the three provided contacts no later than December 16th
Top candidates will be invited for onsite interviews at the sponsoring company’s location. Final candidates will be required to go through additional screening / onboarding as required by MCPHS University.
The MCPHS Biopharmaceutical Industry fellows will be selected on a nationally competitive basis, with interviews at the American Society of Health Systems Pharmacists (ASHP) Midyear meeting.
Applicants must have a Doctor of Pharmacy degree from an ACPE accredited college of pharmacy at the commencement of the program.
Candidates must have strong written and verbal communication skills and a strong interest in pursuing a career within the biopharmaceutical industry.
All candidates must have authorization to work in the United States throughout the duration of the one or two-year fellowship. No visa sponsorship will be provided.
2 openings. Employer will assist with relocation costs.
Additional Salary Information: Fellows will receive a competitive stipend and benefits package, including comprehensive health insurance.
About MCPHS University / Novartis Institutes for BioMedical Research
The Novartis Institutes for BioMedical Research (NIBR) is the global pharmaceutical research organization for Novartis. We are committed to discovering innovative medicines to treat diseases with high unmet medical need. With more than 6,000 scientists and physicians around the world, our open and entrepreneurial culture encourages collaboration as we work to push the boundaries of science to change the practice of medicine.